시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 펩티드 원료의약품 CDMO 서비스 시장 : 인사이트 및 예측(-2030년)
Global Peptide API CDMO Services Market Insights, Forecast to 2030
상품코드 : 1432267
리서치사 : QYResearch
발행일 : 2024년 02월
페이지 정보 : 영문
 라이선스 & 가격 (부가세 별도)
US $ 4,900 ￦ 7,079,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,350 ￦ 10,619,000
PDF (Multi User License) help
PDF, Excel 보고서를 동일 기업내 10명까지 이용하실 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF, Excel, Word 이용 범위와 동일합니다.
US $ 9,800 ￦ 14,159,000
PDF (Enterprise User License) help
PDF, Excel, Word 보고서를 동일 기업내 모든 구성원이 이용하실 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF, Excel, Word 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 펩티드 원료의약품 CDMO 서비스 시장 규모는 2024년 23억 4,221만 달러에서 2030년에는 54억 4,797만 달러로 성장할 것으로 예측되며, 예측 기간중 연간 평균 성장률(CAGR)은 15.11%를 나타낼 전망입니다.

미국/캐나다의 펩티드 원료의약품 CDMO 서비스 시장 규모는 2024년 12억 1,966만 달러에서 2030년에는 27억 5,100만 달러로 성장할 것으로 예측되며, 2024년부터 2030년 예측 기간 중 연평균 복합 성장률(CAGR)은 14.52%를 나타낼 전망입니다.

중국의 펩티드 원료의약품 CDMO 서비스 시장 규모는 2024년 2억 566만 달러에서 2030년에는 6억 3,865만 달러로 성장할 것으로 예측되며, 2024년부터 2030년 예측 기간 중 연평균 복합 성장률(CAGR)은 20.79%를 나타낼 전망입니다.

유럽의 펩티드 원료의약품 CDMO 서비스 시장 규모는 2024년 7억 5,896만 달러에서 2030년에는 16억 5,534만 달러로 성장할 것으로 예측되며, 2024년부터 2030년 예측 기간 중 연평균 복합 성장률(CAGR)은 13.88%를 나타낼 전망입니다.

펩티드 원료의약품 CDMO 서비스 세계 주요 기업에는 Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company등이 있습니다. 2023년, 세계 주요 5개사의 매출 점유율은 약 54.92%였습니다.

세계의 펩티드 원료의약품 CDMO 서비스 시장에 대해 조사했으며, 시장 개요와 함께, 기업별/유형별/용도별/지역별 동향 및 시장 진출기업 개요 등을 제공합니다.

목차

제1장 보고서 개요

제2장 세계의 성장 동향

제3장 주요 시장 진출기업의 경쟁 구도

제4장 펩티드 원료의약품 CDMO 서비스 분석 데이터, 유형별

제5장 펩티드 원료의약품 CDMO 서비스 분석 데이터, 용도별

제6장 북미

제7장 유럽

제8장 중국

제9장 아시아(중국 제외)

제10장 중동 및 아프리카, 라틴아메리카

제11장 주요 진출 기업 개요

제12장 애널리스트의 견해/결론

제13장 부록

LSH
영문 목차

영문목차

The global Peptide API CDMO Services market is projected to grow from US$ 2342.21 million in 2024 to US$ 5447.97 million by 2030, at a Compound Annual Growth Rate (CAGR) of 15.11% during the forecast period.

The US & Canada market for Peptide API CDMO Services is estimated to increase from $ 1219.66 million in 2024 to reach $ 2751.00 million by 2030, at a CAGR of 14.52% during the forecast period of 2024 through 2030.

The China market for Peptide API CDMO Services is estimated to increase from $ 205.66 million in 2024 to reach $ 638.65 million by 2030, at a CAGR of 20.79% during the forecast period of 2024 through 2030.

The Europe market for Peptide API CDMO Services is estimated to increase from $ 758.96 million in 2024 to reach $ 1655.34 million by 2030, at a CAGR of 13.88% during the forecast period of 2024 through 2030.

The global key companies of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company, etc. In 2023, the global top five players had a share approximately 54.92% in terms of revenue.

Report Includes

This report presents an overview of global market for Peptide API CDMO Services market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Peptide API CDMO Services, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Peptide API CDMO Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peptide API CDMO Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Peptide API CDMO Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Peptide API CDMO Services revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company, etc.

Market Segmentation

By Company

Segment by Type

Segment by Application

By Region

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Peptide API CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peptide API CDMO Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide API CDMO Services revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview

2 Global Growth Trends

3 Competition Landscape by Key Players

4 Peptide API CDMO Services Breakdown Data by Type

5 Peptide API CDMO Services Breakdown Data by Application

6 North America

7 Europe

8 China

9 Asia (excluding China)

10 Middle East, Africa, and Latin America

11 Key Players Profiles

12 Analyst's Viewpoints/Conclusions

13 Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기